Clinical Trial Update: Trevisio Post-Approval Study

View source ↗

Summary

Trevisio post-approval study by Abbott Medical Devices has completed and posted results (as of 2026-03-16). The study covers patent foramen ovale, atrial septal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Septal Defect
• Muscular Ventricular Septal Defect
• Patent Foramen Ovale
• Postinfarct Ventricular Septal Defect

Drugs mentioned

• Trevisio

Snippet

Sponsor: Abbott Medical Devices | Conditions: PFO - Patent Foramen Ovale, ASD - Atrial Septal Defect | Status: COMPLETED | Results posted: 2026-03-16